Modified serpinA1 as risk marker for Parkinson’s disease dementia: Analysis of baseline data
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modified serpinA1 as risk marker for Parkinson’s disease dementia: Analysis of baseline data
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-05-17
DOI
10.1038/srep26145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal Fluid α-Synuclein Does Not Discriminate Between Dementia Disorders
- (2017) Petra E. Spies et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
- (2017) Fransje E. Reesink et al. JOURNAL OF ALZHEIMERS DISEASE
- Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition
- (2015) Hsin-Yung Yen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Capillary isoelectric focusing immunoassay as a new nanoscale approach for the detection of oligoclonal bands
- (2014) Steffen Halbgebauer et al. ELECTROPHORESIS
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson’s Disease Dementia
- (2012) Sarah Jesse et al. PLoS One
- Phosphorylated -Synuclein in Parkinson's Disease
- (2012) Y. Wang et al. Science Translational Medicine
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells
- (2011) Y.-C. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recognition and management of Parkinson’s disease during the premotor (prodromal) phase
- (2009) Daniel D Truong et al. Expert Review of Neurotherapeutics
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
- Glycoproteomics in neurodegenerative diseases
- (2009) Hyejin Hwang et al. MASS SPECTROMETRY REVIEWS
- Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
- (2008) Brit Mollenhauer et al. EXPERIMENTAL NEUROLOGY
- Polymers and inflammation: disease mechanisms of the serpinopathies
- (2008) Bibek Gooptu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization
- (2008) Masayuki Yamasaki et al. NATURE
- Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
- (2008) D. Aarsland et al. NEUROLOGY
- Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
- (2008) Annika Öhrfelt et al. NEUROSCIENCE LETTERS
- Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease
- (2008) Peter Brechlin et al. PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation